SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL448]
GTX635686
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Other Application
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL448]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:5000-1:10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHL448
- Concentration1 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Ardanuy J, Johnson R, Dillen C, et al. Pyronaridine tetraphosphate is an efficacious antiviral and anti-inflammatory active against multiple highly pathogenic coronaviruses. mBio. 2023,14(5):e0158723. doi: 10.1128/mbio.01587-23Read this paper
- Arostegui D, Castro K, Schwarz S, et al. Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection. JPGN Rep. 2022,3(1):e152. doi: 10.1097/PG9.0000000000000152Read this paper
- Bullock HA, Fuchs E, Martines RB, et al. Probable vertical transmission of Alpha variant of concern (B.1.1.7) with evidence of SARS-CoV-2 infection in the syncytiotrophoblast, a case report. Front Med (Lausanne). 2022,9:1099408. doi: 10.3389/fmed.2022.1099408Read this paper
- Zhu C, Lee JY, Woo JZ, et al. An intranasal ASO therapeutic targeting SARS-CoV-2. Nat Commun. 2022,13(1):4503. doi: 10.1038/s41467-022-32216-0Read this paper
- Eltobgy MM, Zani A, Kenney AD, et al. Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis. Proc Natl Acad Sci U S A. 2022,119(21):e2202012119. doi: 10.1073/pnas.2202012119Read this paper
- Karki R, Lee S, Mall R, et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol. 2022,7(74):eabo6294. doi: 10.1126/sciimmunol.abo6294Read this paper
- Reagan-Steiner S, Bhatnagar J, Martines RB, et al. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta. Emerg Infect Dis. 2022,28(3):510-517. doi: 10.3201/eid2803.211735Read this paper
- Vazquez C, Swanson SE, Negatu SG, et al. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS One. 2021,16(6):e0253089. doi: 10.1371/journal.pone.0253089Read this paper
- Li J, Lillehoj PB. Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum. ACS Sens. 2021,6(3):1270-1278. doi: 10.1021/acssensors.0c02561Read this paper